Chemours Co
Chemours Co Fundamental Analysis
Chemours Co (2CU.DE) shows moderate financial fundamentals with a PE ratio of 10.80, profit margin of 9.58%, and ROE of 64.20%. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 51.3/100 based on profitability, valuation, growth, and balance sheet metrics. The C grade reflects average fundamentals, with notable risks in certain areas.
Fundamental Health Score
We analyze 2CU.DE's fundamental strength across five key dimensions:
Efficiency Score
Weak2CU.DE struggles to generate sufficient returns from assets.
Valuation Score
Excellent2CU.DE trades at attractive valuation levels.
Growth Score
Weak2CU.DE faces weak or negative growth trends.
Financial Health Score
Moderate2CU.DE shows balanced financial health with some risks.
Profitability Score
Weak2CU.DE struggles to sustain strong margins.
Key Financial Metrics
Is 2CU.DE Expensive or Cheap?
P/E Ratio
2CU.DE trades at 10.80 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, 2CU.DE's PEG of 0.09 indicates potential undervaluation.
Price to Book
The market values Chemours Co at 6.07 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at -2.10 times EBITDA. This is generally considered low.
How Well Does 2CU.DE Make Money?
Net Profit Margin
For every $100 in sales, Chemours Co keeps $9.58 as profit after all expenses.
Operating Margin
Core operations generate 13.57 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $64.20 in profit for every $100 of shareholder equity.
ROA
Chemours Co generates $8.05 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
FCF Per Share
Each share generates $3.22 in free cash annually.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
10.80
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.09
vs 25 benchmark
P/B Ratio
Price to book value ratio
6.07
vs 25 benchmark
P/S Ratio
Price to sales ratio
0.00
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
3.63
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.80
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.64
vs 25 benchmark
ROA
Return on assets percentage
0.08
vs 25 benchmark
ROCE
Return on capital employed
0.15
vs 25 benchmark
How 2CU.DE Stacks Against Its Sector Peers
| Metric | 2CU.DE Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 10.80 | 23.49 | Better (Cheaper) |
| ROE | 64.20% | 883.00% | Weak |
| Net Margin | 9.58% | -94454.00% (disorted) | Weak |
| Debt/Equity | 3.63 | 0.51 | Weak (High Leverage) |
| Current Ratio | 1.80 | 5.14 | Neutral |
| ROA | 8.05% | -6300.00% (disorted) | Weak |
2CU.DE outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Chemours Co's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Cyclical, Commodity, Value
EPS CAGR
N/A
Industry Style: Cyclical, Commodity, Value
FCF CAGR
N/A
Industry Style: Cyclical, Commodity, Value